Global Peri-implantitis Treatment Market Research Report 2022

Report Format: PDF   |   Report ID: 5378660   |   Published Date: July 2022   |   Pages:  82  

Choose License
Peri-implantitis Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Peri-implantitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Surgical Treatment
    Drug Treatment
Segment by Application
    Hospital
    Clinic
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Pfizer
    Cadila Pharmaceuticals
    R.N. Laboratories
    Basic Pharma Life Science
    Prachi Pharmaceuticals
    Healthy Life Pharma
    Geistlich Pharma
    Dawood & Tanner
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peri-implantitis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Surgical Treatment
        1.2.3 Drug Treatment
    1.3 Market by Application
        1.3.1 Global Peri-implantitis Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peri-implantitis Treatment Market Perspective (2017-2028)
    2.2 Peri-implantitis Treatment Growth Trends by Region
        2.2.1 Peri-implantitis Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peri-implantitis Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Peri-implantitis Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Peri-implantitis Treatment Market Dynamics
        2.3.1 Peri-implantitis Treatment Industry Trends
        2.3.2 Peri-implantitis Treatment Market Drivers
        2.3.3 Peri-implantitis Treatment Market Challenges
        2.3.4 Peri-implantitis Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peri-implantitis Treatment Players by Revenue
        3.1.1 Global Top Peri-implantitis Treatment Players by Revenue (2017-2022)
        3.1.2 Global Peri-implantitis Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Peri-implantitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peri-implantitis Treatment Revenue
    3.4 Global Peri-implantitis Treatment Market Concentration Ratio
        3.4.1 Global Peri-implantitis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peri-implantitis Treatment Revenue in 2021
    3.5 Peri-implantitis Treatment Key Players Head office and Area Served
    3.6 Key Players Peri-implantitis Treatment Product Solution and Service
    3.7 Date of Enter into Peri-implantitis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peri-implantitis Treatment Breakdown Data by Type
    4.1 Global Peri-implantitis Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Peri-implantitis Treatment Forecasted Market Size by Type (2023-2028)
5 Peri-implantitis Treatment Breakdown Data by Application
    5.1 Global Peri-implantitis Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Peri-implantitis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peri-implantitis Treatment Market Size (2017-2028)
    6.2 North America Peri-implantitis Treatment Market Size by Country (2017-2022)
    6.3 North America Peri-implantitis Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Peri-implantitis Treatment Market Size (2017-2028)
    7.2 Europe Peri-implantitis Treatment Market Size by Country (2017-2022)
    7.3 Europe Peri-implantitis Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peri-implantitis Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Peri-implantitis Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Peri-implantitis Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Peri-implantitis Treatment Market Size (2017-2028)
    9.2 Latin America Peri-implantitis Treatment Market Size by Country (2017-2022)
    9.3 Latin America Peri-implantitis Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peri-implantitis Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Peri-implantitis Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Peri-implantitis Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Peri-implantitis Treatment Introduction
        11.1.4 Pfizer Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Cadila Pharmaceuticals
        11.2.1 Cadila Pharmaceuticals Company Detail
        11.2.2 Cadila Pharmaceuticals Business Overview
        11.2.3 Cadila Pharmaceuticals Peri-implantitis Treatment Introduction
        11.2.4 Cadila Pharmaceuticals Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.2.5 Cadila Pharmaceuticals Recent Development
    11.3 R.N. Laboratories
        11.3.1 R.N. Laboratories Company Detail
        11.3.2 R.N. Laboratories Business Overview
        11.3.3 R.N. Laboratories Peri-implantitis Treatment Introduction
        11.3.4 R.N. Laboratories Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.3.5 R.N. Laboratories Recent Development
    11.4 Basic Pharma Life Science
        11.4.1 Basic Pharma Life Science Company Detail
        11.4.2 Basic Pharma Life Science Business Overview
        11.4.3 Basic Pharma Life Science Peri-implantitis Treatment Introduction
        11.4.4 Basic Pharma Life Science Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.4.5 Basic Pharma Life Science Recent Development
    11.5 Prachi Pharmaceuticals
        11.5.1 Prachi Pharmaceuticals Company Detail
        11.5.2 Prachi Pharmaceuticals Business Overview
        11.5.3 Prachi Pharmaceuticals Peri-implantitis Treatment Introduction
        11.5.4 Prachi Pharmaceuticals Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.5.5 Prachi Pharmaceuticals Recent Development
    11.6 Healthy Life Pharma
        11.6.1 Healthy Life Pharma Company Detail
        11.6.2 Healthy Life Pharma Business Overview
        11.6.3 Healthy Life Pharma Peri-implantitis Treatment Introduction
        11.6.4 Healthy Life Pharma Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.6.5 Healthy Life Pharma Recent Development
    11.7 Geistlich Pharma
        11.7.1 Geistlich Pharma Company Detail
        11.7.2 Geistlich Pharma Business Overview
        11.7.3 Geistlich Pharma Peri-implantitis Treatment Introduction
        11.7.4 Geistlich Pharma Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.7.5 Geistlich Pharma Recent Development
    11.8 Dawood & Tanner
        11.8.1 Dawood & Tanner Company Detail
        11.8.2 Dawood & Tanner Business Overview
        11.8.3 Dawood & Tanner Peri-implantitis Treatment Introduction
        11.8.4 Dawood & Tanner Revenue in Peri-implantitis Treatment Business (2017-2022)
        11.8.5 Dawood & Tanner Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Peri-implantitis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Surgical Treatment Table 3. Key Players of Drug Treatment Table 4. Global Peri-implantitis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Peri-implantitis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Peri-implantitis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Peri-implantitis Treatment Market Share by Region (2017-2022) Table 8. Global Peri-implantitis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Peri-implantitis Treatment Market Share by Region (2023-2028) Table 10. Peri-implantitis Treatment Market Trends Table 11. Peri-implantitis Treatment Market Drivers Table 12. Peri-implantitis Treatment Market Challenges Table 13. Peri-implantitis Treatment Market Restraints Table 14. Global Peri-implantitis Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Peri-implantitis Treatment Market Share by Players (2017-2022) Table 16. Global Top Peri-implantitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peri-implantitis Treatment as of 2021) Table 17. Ranking of Global Top Peri-implantitis Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Peri-implantitis Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Peri-implantitis Treatment Product Solution and Service Table 21. Date of Enter into Peri-implantitis Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Peri-implantitis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Peri-implantitis Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Peri-implantitis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Peri-implantitis Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Peri-implantitis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Peri-implantitis Treatment Revenue Market Share by Application (2017-2022) Table 29. Global Peri-implantitis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Peri-implantitis Treatment Revenue Market Share by Application (2023-2028) Table 31. North America Peri-implantitis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Peri-implantitis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Peri-implantitis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Peri-implantitis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Peri-implantitis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Peri-implantitis Treatment Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Peri-implantitis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Peri-implantitis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Peri-implantitis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Peri-implantitis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Pfizer Company Detail Table 42. Pfizer Business Overview Table 43. Pfizer Peri-implantitis Treatment Product Table 44. Pfizer Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 45. Pfizer Recent Development Table 46. Cadila Pharmaceuticals Company Detail Table 47. Cadila Pharmaceuticals Business Overview Table 48. Cadila Pharmaceuticals Peri-implantitis Treatment Product Table 49. Cadila Pharmaceuticals Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 50. Cadila Pharmaceuticals Recent Development Table 51. R.N. Laboratories Company Detail Table 52. R.N. Laboratories Business Overview Table 53. R.N. Laboratories Peri-implantitis Treatment Product Table 54. R.N. Laboratories Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 55. R.N. Laboratories Recent Development Table 56. Basic Pharma Life Science Company Detail Table 57. Basic Pharma Life Science Business Overview Table 58. Basic Pharma Life Science Peri-implantitis Treatment Product Table 59. Basic Pharma Life Science Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 60. Basic Pharma Life Science Recent Development Table 61. Prachi Pharmaceuticals Company Detail Table 62. Prachi Pharmaceuticals Business Overview Table 63. Prachi Pharmaceuticals Peri-implantitis Treatment Product Table 64. Prachi Pharmaceuticals Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 65. Prachi Pharmaceuticals Recent Development Table 66. Healthy Life Pharma Company Detail Table 67. Healthy Life Pharma Business Overview Table 68. Healthy Life Pharma Peri-implantitis Treatment Product Table 69. Healthy Life Pharma Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 70. Healthy Life Pharma Recent Development Table 71. Geistlich Pharma Company Detail Table 72. Geistlich Pharma Business Overview Table 73. Geistlich Pharma Peri-implantitis Treatment Product Table 74. Geistlich Pharma Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 75. Geistlich Pharma Recent Development Table 76. Dawood & Tanner Company Detail Table 77. Dawood & Tanner Business Overview Table 78. Dawood & Tanner Peri-implantitis Treatment Product Table 79. Dawood & Tanner Revenue in Peri-implantitis Treatment Business (2017-2022) & (US$ Million) Table 80. Dawood & Tanner Recent Development Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Global Peri-implantitis Treatment Market Share by Type: 2021 VS 2028 Figure 2. Surgical Treatment Features Figure 3. Drug Treatment Features Figure 4. Global Peri-implantitis Treatment Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Others Case Studies Figure 8. Peri-implantitis Treatment Report Years Considered Figure 9. Global Peri-implantitis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Peri-implantitis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Peri-implantitis Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global Peri-implantitis Treatment Market Share by Players in 2021 Figure 13. Global Top Peri-implantitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peri-implantitis Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Peri-implantitis Treatment Revenue in 2021 Figure 15. North America Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Peri-implantitis Treatment Market Share by Country (2017-2028) Figure 17. United States Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Peri-implantitis Treatment Market Share by Country (2017-2028) Figure 21. Germany Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Peri-implantitis Treatment Market Share by Region (2017-2028) Figure 29. China Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Peri-implantitis Treatment Market Share by Country (2017-2028) Figure 37. Mexico Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Peri-implantitis Treatment Market Share by Country (2017-2028) Figure 41. Turkey Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Peri-implantitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Pfizer Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 44. Cadila Pharmaceuticals Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 45. R.N. Laboratories Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 46. Basic Pharma Life Science Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 47. Prachi Pharmaceuticals Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 48. Healthy Life Pharma Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 49. Geistlich Pharma Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 50. Dawood & Tanner Revenue Growth Rate in Peri-implantitis Treatment Business (2017-2022) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research